Related Experiment Videos

Studies on the effects of hyperkalemia on serum and myocardial digoxin concentration in dogs

Japanese Heart Journal
|November 1, 1983
PubMed

Insights

Hyperkalemia significantly lowers myocardial digoxin concentration despite higher serum levels. This suggests potassium competes with digoxin for uptake into heart muscle, impacting its effectiveness.

Area of Science:

  • Cardiovascular Physiology
  • Pharmacology
  • Biochemistry

Background:

  • Digoxin is a crucial medication for heart failure and arrhythmias.
  • Hyperkalemia, a common complication in patients with heart conditions, can alter drug efficacy.
  • Understanding the interaction between potassium and digoxin is vital for patient management.

Purpose of the Study:

  • To investigate the impact of hyperkalemia on digoxin concentration in serum and heart muscle.
  • To examine the relationship between hyperkalemia, digoxin levels, and hemodynamic changes.
  • To explore potential competitive antagonism between potassium and digoxin uptake.

Main Methods:

  • Studied 31 normal dogs divided into hyperkalemic (HK) and normokalemic (NK) groups.
  • Measured serum and myocardial concentrations of digoxin (DX).
  • Assessed myocardial sodium concentration and left ventricular maximal pressure change over time (LV max dP/dt).

Main Results:

  • Myocardial DX concentration was significantly lower in the HK group compared to the NK group.
  • Serum DX concentration was significantly higher in the HK group.
  • Myocardial sodium concentration was lower in the HK group, and no increase in LV max dP/dt was observed after DX administration in HK dogs.

Conclusions:

  • Hyperkalemia reduces myocardial digoxin uptake.
  • A competitive antagonism between myocardial potassium and digoxin uptake is suggested.
  • These findings have implications for digoxin use in patients with hyperkalemia.

Related Concept Videos